Inovio Pharma (INO) Posts Q4 Loss of 25c/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.32 +6.45%
EPS Growth %: +75.9%
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +75.9%
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q4 EPS of ($0.25), which may not compare with the analyst estimate of ($0.20). Revenue for the quarter came in at $5.94 million versus the consensus estimate of $6.96 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- BlockchainK2 plans private placement to raise up to $130,000
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
